In 1994, the innovative minds of a research group at the University of Munich, led by Amgen vice president Dr. Peter Kufer, made a monumental discovery. Aiming to use the human immune system to fight cancer cells, Dr. Kufer’s team invented Bispecific T-cell Engager (BiTE®) technology.
Karen Blanchette Lasater, Ph.D., R.N., FAANAssociate Professor of NursingUniversity of Pennsylvania
Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine, discusses the interconnected condition of cardiovascular-kidney-metabolic (CKM)…
.yellow { background-color: #FDB81E; color: #323A45; } .yellow:hover { background-color: #FFF1D2; color: #323A45; }
AHRQ Announces Interest in Research to Improve Treatment and Management of Menopause SymptomsAHRQ Announces Interest in Health Services Research to Improve Care Delivery, Access, Quality,…
This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.
National Action Alliance for Patient and Workforce Safety Webinar announcement
Karen Blanchette Lasater, Ph.D., R.N., FAANAssociate Professor of NursingUniversity of Pennsylvania
AHRQ’s Healthcare-Associated Infections (HAI) Division funds clinical and health services research to develop the knowledge and practical tools used on the frontlines to prevent infections…
AHRQ Announces Interest in Research to Improve Treatment and Management of Menopause SymptomsAHRQ Announces Interest in Health Services Research to Improve Care Delivery, Access, Quality,…
This review focuses on the diagnostic accuracy of brief OCD assessment tools and the treatment of OCD in children. The 2012 American Academy of Child…
